Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples. - Wikidata - awgldk - TriplyDB

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.

http://www.wikidata.org/entity/Q37317218

about

Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers.

P2860

Q37342600-93DE3884-F7AF-415F-8DFE-7364A8EBCD79

P2860

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.

http://www.wikidata.org/entity/Q37317218

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular classification of ca ...... gy and limited tissue samples.

@en

Molecular classification of ca ...... gy and limited tissue samples.

@nl

type

label

Molecular classification of ca ...... gy and limited tissue samples.

@en

Molecular classification of ca ...... gy and limited tissue samples.

@nl

prefLabel

Molecular classification of ca ...... gy and limited tissue samples.

@en

Molecular classification of ca ...... gy and limited tissue samples.

@nl

P1433

Q37317218-E719E26B-6964-40D7-B43A-FA394750ECD4

P1476

Q37317218-54DD40A9-FBBF-447A-88CA-F62A6FB94287

P2093

Q37317218-099D7C1D-F4DD-4396-9655-A0CC906D5F4B

Q37317218-12397DA0-9CFD-4600-B873-D52576B8F253

Q37317218-39D1D413-2010-46F5-9A8E-9960F24312E1

Q37317218-80981076-A6C9-49A1-9F7A-31F816EF135C

Q37317218-848F7BB1-01F7-4A0C-8CFF-4C4D9A7CACB3

Q37317218-8EC00203-6D54-435D-828C-7F5894296BB7

Q37317218-94C2C230-3F08-49A8-B9D4-7ADE6A0522A6

Q37317218-B29A4D92-DBF2-436E-B497-EA3BA5504292

P2860

Q37317218-0BEF36F3-B3E7-44F8-B8D9-341CF03FFDC6

Q37317218-137DE027-6FF1-4853-AB7A-D83C0BDA8D89

Q37317218-15E9980B-51CE-4545-9497-E31301B63DBD

Q37317218-19379C8F-C887-4051-9900-198BD49714BE

Q37317218-24F25E0A-DC61-45FA-AB66-A00154518F19

Q37317218-284115E3-504B-4B3B-9BC3-7F940431760C

Q37317218-3E7A30BA-7872-42D9-856F-D4DC0CEE449D

Q37317218-3F4C31D3-7E99-4213-B7C5-E1B0AAA09408

Q37317218-42FB70C9-F4E4-4BFE-8A78-73750B2A2E77

Q37317218-446B7EDE-281B-4AE3-9C4C-2513A9DFEEDB

P304

Q37317218-444333FF-C969-4B31-9EFB-CDF2F6C5FA4C

P31

Q37317218-6F872792-C80A-4C7F-ABE0-37FD38645474

P356

Q37317218-8D9FE089-E8D5-44DF-BAA2-678D8B00C629

P407

Q37317218-571CC156-B4AE-495D-8442-1E6DCE78C452

P433

Q37317218-D9C9A440-C9B6-433A-AFF9-277E27C1A0CD

P478

Q37317218-0F3555C6-A423-408F-9BB8-3FADCD01E5B2

P577

Q37317218-E650E25C-DD29-4AD9-AF5E-3735F78738C2

P5875

Q37317218-F549036F-CAD6-4784-ADE1-9AE4481A4C30

P698

Q37317218-B0DBCC5F-47EC-4395-9171-C161CAADB126

P932

Q37317218-54384B7C-CC85-40F4-BF42-87413D24DBAB

P356

ONCOTARGET.8449

P1433

P1476

Molecular classification of ca ...... gy and limited tissue samples.

@en

P2093

Brock E Schroeder

http://www.w3.org/2001/XMLSchema#string

Catherine A Schnabel

http://www.w3.org/2001/XMLSchema#string

Elena F Brachtel

http://www.w3.org/2001/XMLSchema#string

Karen A Cherkis

http://www.w3.org/2001/XMLSchema#string

Peggy S Sullivan

http://www.w3.org/2001/XMLSchema#string

Sarah E Kerr

http://www.w3.org/2001/XMLSchema#string

Sarah M Dry

http://www.w3.org/2001/XMLSchema#string

Theresa N Operaña

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer

Circulating tumor DNA as a liquid biopsy for cancer.

Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.

Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification.

Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification

P304

27220-27231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.8449

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299474212

http://www.w3.org/2001/XMLSchema#string

P698

27034010

http://www.w3.org/2001/XMLSchema#string

P932

5053644

http://www.w3.org/2001/XMLSchema#string